Status:
COMPLETED
Esophagogastrectomy Versus Extended Gastrectomy in AEG II
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Carcinomas of the Esophagogastric Junction
Eligibility:
All Genders
18+ years
Brief Summary
Comparison of the oncological outcome of patients who underwent esophagogastrectomy versus extended gastrectomy due to carcinomas of the esophagogastric junction (Siewert type II)
Detailed Description
The esophagogastric junction (EGJ) is an anatomical region where different tumour entities which should be treated with different surgical approaches. Carcinomas within this area cause discordance con...
Eligibility Criteria
Inclusion
- Carcinoma of the esophagogastric junction (AEG type II)
- Age of Minimum 18 years
Exclusion
- non
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT02302118
Start Date
April 1 2013
End Date
November 1 2015
Last Update
December 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Hamburg Eppendorf
Hamburg, Germany, 20246